NFE2L2 and ovarian cancer: Although SYVN1 mediates erastin-induced ferroptosis in ovarian cancer cells by facilitating ubiquitination-dependent degradation of SLC7A11[66], direct evidence for SYVN1-dependent NFE2L2 degradation during ferroptosis remains limited.